E-LIB Suche - Ergebnisse für: Gamberi, B.

1

P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFR..:

Offidani, M. ; Morè, S. ; Cavo, M....
HemaSphere. 7 (2023) S2 - p. 30-31 , 2023

Link: https://doi.org/10.1097/..

2

P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULT..:

Fazio, F. ; Di Rocco, A. ; Giaimo, M. T....
HemaSphere. 6 (2022) - p. 793-794 , 2022

Link: https://doi.org/10.1097/..

3

Rare High Risk IgH Translocations in Newly Diagnosed Multip..:

Marzocchi, G. ; Testoni, N. ; Ameli, G....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e46-e47 , 2015

Link: https://doi.org/10.1016/..

4

Lenalidomide maintenance causes persistence of abnormal pro..:

Gamberi, B. ; Rivolti, E. ; Quaresima, M....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e146-e147 , 2015

Link: https://doi.org/10.1016/..

5

Bortezomib based regimen in young high risk Multiple Myelom..:

Quaresima, M. ; Rivolti, E. ; Gamberi, B....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e172-e173 , 2015

Link: https://doi.org/10.1016/..

6

Continuous Lenalidomide and Low-Dose Dexamethasone for the ..:

Dimopoulos, M. ; Cheung, M. ; Roussel, M....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e139-e140 , 2015

Link: https://doi.org/10.1016/..

7

Analysis of microsatellite instability in chronic lymphopro..:

Volpe, G. ; Gamberi, B. ; Pastore, C....
Annals of Hematology. 72 (1996) 2 - p. 67-71 , 1996

Link: https://doi.org/10.1007/..

8

Comparative effects of racemic verapamil vs R-verapamil on ..:

Visani, G. ; Fogli, M. ; Tosi, P....
Annals of Hematology. 66 (1993) 6 - p. 273-276 , 1993

Link: https://doi.org/10.1007/..

9

Granulocyte-macrophage colony-stimulating factor in acute n..:

Visani, G. ; Damiani, D. ; Cenacchi, A....
Annals of Hematology. 63 (1991) 5 - p. 276-281 , 1991

Link: https://doi.org/10.1007/..

10

Sensitivity of chronic myeloid leukemia hemopoietic progeni..:

Visani, G. ; Lemoli, R. M. ; Tosi, P....
Blut. 60 (1990) 5 - p. 287-290 , 1990

Link: https://doi.org/10.1007/..

11

Incidence, mortality, and survival of hematological maligna..:

Mangone L ; Penna D ; Marinelli F...
info:eu-repo/semantics/altIdentifier/pmid/37534259. , 2023

Link: https://hdl.handle.net/1..

12

P36 BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED AND REFR..:

Offidani, M ; Morè, S ; Cavo, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171581/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Survival Risk Scores for Real-Life Relapsed/Refractory Mult..:

Morabito F ; Zamagni E ; Conticello C...
info:eu-repo/semantics/altIdentifier/pmid/35924160. , 2022

Link: https://hdl.handle.net/1..

14

PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN R..:

Bruzzese, A ; Derudas, D ; Galli, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429134/. , 2022

Link: http://www.ncbi.nlm.nih...

15

P902: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULT..:

Fazio, F ; Di Rocco, A ; Giaimo, M. T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429255/. , 2022

Link: http://www.ncbi.nlm.nih...